Description

4-(Benzoyl(((4,5-Dihydro-1H-Imidazol-2-Yl)(2-Hydroxybutyl)Amino)Methyl )Amino)Butyric Acid is a specialized organic compound featuring a complex molecular architecture that combines benzoyl, imidazoline, and carboxylic acid functional groups. This structure makes it a valuable intermediate for the synthesis of advanced pharmaceutical agents and fine chemicals, where its multifunctional nature allows for precise molecular modifications. It is primarily sought by research and development chemists in the pharmaceutical, agrochemical, and specialty chemical industries for creating novel bioactive molecules.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of potential drug candidates, particularly those targeting neurological or cardiovascular pathways.
• Agrochemical Research: Used in developing novel active ingredients for crop protection products, such as herbicides or fungicides.
• Ligand Synthesis: Serves as a precursor for creating complex chelating agents or ligands used in catalysis and metal ion sequestration.
• Bioconjugation Chemistry: The reactive functional groups enable its use in linking molecules, useful in probe or diagnostic reagent development.
• Polymer Modification: Can be incorporated into polymer chains to impart specific chemical functionality or bioactivity.
• Academic & Industrial R&D: A crucial reagent for exploratory chemistry in university and corporate research laboratories.

Basic Information

Item	Detail
Product Name	4-(Benzoyl(((4,5-Dihydro-1H-Imidazol-2-Yl)(2-Hydroxybutyl)Amino)Methyl )Amino)Butyric Acid
CAS No.	81186-19-8
Molecular Formula	C17H24N4O4
Molecular Weight	348.40 g/mol
Synonyms	4-[Benzoyl-[(4,5-dihydro-1H-imidazol-2-yl)-(2-hydroxybutyl)amino]methylamino]butanoic acid; 4-(Benzoyl(((4,5-Dihydro-1H-Imidazol-2-Yl)(2-Hydroxybutyl)Amino)Methyl)Amino)Butyric Acid; 2-[Benzoyl-[(4-butanoic acid)amino]methyl]-N-(2-hydroxybutyl)-4,5-dihydro-1H-imidazole-1-ethanamine; Butanoic acid, 4-[[benzoyl[(4,5-dihydro-1H-imidazol-2-yl)(2-hydroxybutyl)amino]methyl]amino]-; Lofexidine Impurity; Lofexidine Related Compound
EINECS	Contact for details

Quality Control

Our 4-(Benzoyl(((4,5-Dihydro-1H-Imidazol-2-Yl)(2-Hydroxybutyl)Amino)Methyl )Amino)Butyric Acid is produced under a strict quality management system. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing all specifications are provided with every shipment. We support compliance with cGMP and ICH guidelines for pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.